Literature DB >> 22214215

Immune function in female B(6)C(3)F(1) mice is modulated by DE-71, a commercial polybrominated diphenyl ether mixture.

Patricia A Fair1, Hui-Chen Stavros, Meagan A M Mollenhauer, Jamie C DeWitt, Natasha Henry, Kurunthachalam Kannan, Se Hun Yun, Gregory D Bossart, Deborah E Keil, Margie M Peden-Adams.   

Abstract

Polybrominated diphenyl ethers (PBDEs) are an important class of flame-retardants that are environmentally persistent and bioaccumulative. Toxicity of these compounds has become a concern because detectable levels of PBDEs are present in humans and wildlife and they are structurally similar to polychlorinated biphenyls (PCBs). This study examined the effects of the commercial penta-BDE mixture, DE-71, in adult female B(6)C(3)F(1) mice on hematology, serum clinical chemistry, thyroid hormones, tissue histology, and several immunotoxicity end-points (lymphocyte proliferation, NK cell activity, splenic immunophenotypes, and SRBC-specific-IgM production). Mice were exposed via oral gavage for 28 days to achieve total administered doses (TAD) of 0, 0.5, 5, 50, or 100 mg/kg. No changes in histology, clinical chemistry, body or organ weights were observed. Serum total T3 and T4 levels were not altered by any of the DE-71 treatments. Peripheral blood monocyte numbers were decreased by the 0.5, 5, and 50 mg/kg treatments, but not by the 100 mg/kg TAD concentration. Compared to controls, mitogen-stimulated T- and B-cell proliferation was increased by the 100 mg/kg TAD concentration (ED(50) = 60 mg/kg TAD [2.14 mg/kg/day] and 58 mg/kg TAD [2.57 mg/kg/day], respectively). NK cell activity was decreased compared to controls by the 100 mg/kg TAD concentration (ED(50) = 20 mg/kg TAD [0.7 mg/kg/day]). No alterations were noted in thymic T-cell populations or in SRBC-specific-IgM production. Numbers of CD19(+)CD21(-), CD19(+)CD21(+), CD4(+)CD8(-), CD4(-)CD8(+), CD4(-)CD8(-), and MHC-II(+) cells in the spleen were not affected. However, the numbers of splenic CD4(+)CD8(+) cells were decreased compared to the controls by 0.5, 5, and 100 mg/kg TAD. This study provides an assessment of the systemic toxicity and immunotoxicity of DE-71, and indicates that immune parameters are modulated at exposure concentrations lower than previously reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214215     DOI: 10.3109/1547691X.2011.643418

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  5 in total

1.  Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts.

Authors:  Noriko Kanaya; Lauren Bernal; Gregory Chang; Takuro Yamamoto; Duc Nguyen; Yuan-Zhong Wang; June-Soo Park; Charles Warden; Jinhui Wang; Xiwei Wu; Timothy Synold; Michele Rakoff; Susan L Neuhausen; Shiuan Chen
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 2.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

3.  Long-term exposure to decabrominated diphenyl ether impairs CD8 T-cell function in adult mice.

Authors:  Weihong Zeng; Ying Wang; Zhicui Liu; Asma Khanniche; Qingliang Hu; Yan Feng; Weiyi Ye; Jianglong Yang; Shujun Wang; Lin Zhou; Hao Shen; Yan Wang
Journal:  Cell Mol Immunol       Date:  2014-04-07       Impact factor: 11.530

4.  Residential levels of polybrominated diphenyl ethers and risk of childhood acute lymphoblastic leukemia in California.

Authors:  Mary H Ward; Joanne S Colt; Nicole C Deziel; Todd P Whitehead; Peggy Reynolds; Robert B Gunier; Marcia Nishioka; Gary V Dahl; Stephen M Rappaport; Patricia A Buffler; Catherine Metayer
Journal:  Environ Health Perspect       Date:  2014-06-03       Impact factor: 9.031

5.  Effects of the Commercial Flame Retardant Mixture DE-71 on Cytokine Production by Human Immune Cells.

Authors:  Thit Mynster Kronborg; Juliana Frohnert Hansen; Claus Henrik Nielsen; Louise Ramhøj; Marie Frederiksen; Katrin Vorkamp; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.